Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

What areas does the Drug Office, Department of Health usually focus on during routine inspections, and how should we prepare?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q352 · Category H: Licensed operations and routine regulatory oversight (Q351–Q400)
Routine inspections by the Department of Health are intended to ensure that licence holders continue to comply with the relevant legislation and codes of practice. Inspections are usually unannounced, although advance notice may also be given. The main areas checked include: 1. Premises and facilities: whether they meet the standards set at the time of licensing, particularly whether the warehouse environment for medicine storage meets the requirements. 2. Documents and records: the main focus of the inspection, including records of medicine purchases, sales and stock, as well as temperature monitoring and staff training records. 3. Operation of the Quality Management System: inspectors will sample-check whether your Standard Operating Procedures (SOPs) are being implemented effectively. 4. Personnel qualifications and responsibilities: ensuring that personnel in key roles have the relevant qualifications and clearly understand their responsibilities. To prepare, ensure all documents and records are well organised and readily accessible, and provide staff with regular training and mock inspection exercises so they can remain composed and answer questions accurately during an inspection.

📘 Regulatory basis

The Pharmacy and Poisons Ordinance (Cap. 138) authorises the Director of Health or an authorised person to enter licensed premises at any reasonable time to inspect whether the licence holder is complying with the requirements of the Ordinance.

📗 Drew Tang's recommendations

We view an inspection as a “free health check” of the company’s compliance system. Rather than responding passively, prepare proactively. We recommend that clients establish an “inspection preparation folder” containing copies or an index of all documents that may be reviewed. During the inspection, assign a senior employee familiar with the situation to accompany the inspectors throughout and answer questions clearly and accurately, making a positive impression of professionalism and rigour.

📕 Risk notice

Providing false or misleading information during an inspection is a serious offence. If incomplete records or signs of falsification are discovered, you may face severe penalties. In addition, obstructing inspectors in the performance of their duties may constitute a criminal offence. Cooperate with the inspection openly and honestly.

Back to Category H: Licensed Operations and Routine Oversight (Q351-Q400) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗